The dry eye disease treatment landscape has expanded dramatically — from simple artificial tear recommendations to sophisticated multimodal protocols involving intense pulsed light (IPL) therapy, amniotic membrane grafts, scleral lens fitting, perfluorocarbon-based drops, and meibomian gland expression devices. This therapeutic expansion has created an administrative complexity expansion in parallel: each treatment modality carries its own documentation requirements, scheduling protocols, and in many cases prior authorization demands. Cornea and dry eye specialty practices that have not built an administrative infrastructure commensurate with their clinical sophistication are leaving revenue on the table and creating documentation vulnerabilities. Virtual assistants with cornea subspecialty training are filling that infrastructure gap.
Scleral Lens Fitting Documentation: A Multi-Visit Workflow
Scleral lens fitting for keratoconus, post-LASIK ectasia, ocular surface disease, and severe dry eye is a multi-visit, iterative process. Initial fitting requires anterior segment OCT vault clearance measurements, trial lens assessment, and detailed fitting notes documenting lens parameters, corneal clearance, limbal clearance, and initial visual acuity. Subsequent fitting visits involve parameter modifications based on wear feedback, re-assessment of vault and limbal clearance, and eventual finalization of the definitive lens prescription.
This fitting series generates a documentation package — typically four to eight visits — that must be maintained in a format suitable for insurance coverage appeals (most commercial payers require documentation of medical necessity for scleral lens coverage) and lens reorder management. When the definitive lens arrives and is dispensed, a dispensing visit note and follow-up schedule must be generated.
VAs assigned to scleral lens coordination maintain fitting progress files for each patient, track lens parameter history across fitting visits, prepare insurance coverage requests with the required medical necessity documentation (including underlying diagnosis confirmation, corneal topography reports, and prior contact lens failure documentation), coordinate with scleral lens fabrication laboratories on order status, and schedule follow-up visits according to the fitting protocol. This coordination function keeps complex multi-visit fitting cases moving without requiring physician or technician time for administrative follow-through.
Amniotic Membrane Prior Authorization
Amniotic membrane products — including PROKERA (BioTissue), AmbioDisk (Katena), and related cryopreserved or dehydrated membrane devices — are used for severe dry eye, persistent epithelial defects, and corneal wound healing. Medicare and commercial payer coverage for amniotic membrane requires prior authorization in most cases, and the documentation package must demonstrate that conventional treatment approaches have been attempted and failed.
The prior authorization process requires compiling a treatment history that documents prior use of artificial tears, prescription drops (cyclosporine, lifitegrast), punctal plugs, moisture chamber goggles, and any prior therapeutic contact lens trials. Clinical findings justifying membrane use — including staining patterns, Schirmer test results, osmolarity measurements, and symptom severity scores — must accompany the authorization request.
According to CMS coding and coverage guidance, improper documentation of treatment failure history is the most common cause of amniotic membrane authorization denial. VAs with cornea billing experience maintain treatment history templates for each active patient, ensuring that prior therapy documentation is systematically recorded from the first visit so that authorization packages can be assembled without chart mining at the time of request.
IPL Treatment Series Scheduling and Documentation
Intense pulsed light (IPL) therapy for meibomian gland dysfunction-associated dry eye is typically delivered in a series of four sessions at three to four week intervals, with maintenance sessions every three to six months thereafter. This recurring treatment series requires structured scheduling — spacing sessions at the correct interval, coordinating device availability, ensuring that patients complete the full series rather than dropping off after initial improvement, and documenting treatment parameters (fluence, pulse duration, number of passes) for each session.
VAs managing IPL treatment series maintain a series tracking calendar for every active IPL patient, send pre-session preparation instructions (avoiding sun exposure, discontinuing photosensitizing medications), confirm appointments at the required spacing interval, document treatment parameter summaries in a standardized format for physician review, and schedule maintenance sessions automatically as initial series are completed.
Series completion tracking is particularly important: IPL's clinical benefit is cumulative, and patients who stop after two sessions due to scheduling difficulty miss the full therapeutic benefit. VA-managed scheduling reminders and follow-up for incomplete series improve series completion rates by 20–30% compared to unmanaged scheduling in practices that have implemented the protocol.
Osmolarity and Meibography Result Tracking
Modern dry eye evaluation includes osmolarity testing (TearLab or i-Plex Osmolarity System) and meibography (LipiScan or equivalent infrared imaging), generating quantitative data points that must be tracked longitudinally to assess disease severity and treatment response. Osmolarity values from each eye, meibograph scores (Meibomian Gland Score or JENVIS grading), and lid wiper epitheliopathy grades all require documentation and trend tracking across visits.
VAs maintain longitudinal dry eye data logs for each patient — updated after every visit with the current osmolarity values, meibography findings, and symptom scores (SPEED or OSDI questionnaire results). These trend summaries are prepared before each follow-up appointment and presented to the physician in a standardized format, enabling rapid assessment of treatment response without requiring the physician to reconstruct the trend from individual visit notes.
The Cornea Subspecialty VA Case
Cornea and dry eye practices operate with clinical complexity that rivals retina subspecialties in terms of documentation density per patient. A VAs at $1,400–$2,200 per month who manages scleral lens coordination, amniotic membrane prior authorization, IPL scheduling, and diagnostic data tracking delivers a documentation infrastructure that protects revenue, improves treatment series completion, and maintains compliance across the practice's most complex patient workflows. For cornea and dry eye practices ready to build that infrastructure, Stealth Agents provides VAs with the subspecialty background to deliver it.
Sources
- Cornea Society, Scleral Lens Education and Practice Standards, 2023
- Tear Film and Ocular Surface Society (TFOS), DEWS II Diagnostic Methodology Report, 2022
- CMS, HCPCS Billing and Coverage Guidelines for Amniotic Membrane Products (V2790), 2024